Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Zuse Institute Berlin
Deal Size : Undisclosed
Deal Type : Collaboration
Qanatpharma, Zuse Institute Berlin, Enamine and Proteros Announce Collaboration
Details : An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to prevent delayed cerebral ischemia in patients with subarachnoid hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
July 09, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Zuse Institute Berlin
Deal Size : Undisclosed
Deal Type : Collaboration